Failure of the Neurotrophic ACTH(4–10) Analogue (BIM 22015) to Attenuate the AF64A-Induced Cholinergic Lesion in Rat Hippocampus

  • Heide Hörtnagl
  • Grazyna Sobal
  • Oleh Hornykiewicz
Part of the Advances in Behavioral Biology book series (ABBI, volume 44)

Abstract

ACTH derived peptides including ACTH(4–9) and ACTH (4–10) possess a neurotrophic potential (Gispen, 1990), but are devoid of corticotrophic action (De Wied, 1969). These ACTH-analogues have been shown to facilitate various forms of neuronal plasticity and to accelerate nerve recovery from mechanical trauma or neurotoxic damage. In the periphery, the neurotrophic properties of ACTH-like peptides have been most extensively studied in the rat or rabbit nerve crush model (Strand and Kung, 1980; Bijlsma et al., 1983; Tonnaer et al., 1992). Beneficial effects have also been achieved in neuropathies of various etiologies in rat and man, including cisplatin- or toxol-induced neuropathy (Gerritsen von der Hoop et al., 1990; Hamers et al., 1993) or diabetic neuropathy (Van der Zee et al., 1990). In the central nervous system, however, the efficacy of these peptides is less convincing and appears to depend on the type of damage and the brain region studied. Although in the rat ACTH fragments reduce hippocampal morphologic correlates of brain aging (Landfield et al., 1981) and improve behavioural recovery from septal lesions and parafascicular thalamic nucleus injury (Isaacson and Poplawsky, 1983; Nyakas et al., 1985), neither serotonergic fibers degenerating in the aging rat hippocampus nor neocortical or hippocampal lesions were affected by ACTH (4–9) (Van Luijtelaar et al., 1992; Mc Daniel et al., 1991). Moreover, no positive effects on cognitive functioning or neurotransmitter markers in patients with dementia of the Alzheimer’s type have been found (Jolkkonen et al., 1985; Miller et al., 1993). In the present investigation we addressed the question whether the ACTH (4–10) analogue has the potential to attenuate a cholinergic lesion of the septo-hippocampal pathway induced by the cholinergic neurotoxin ethylcholine aziridinium (AF64A). For this purpose, AF64A-treated rats received once or twice daily injections of various doses of ACTH(4–10) for 3 weeks. ACTH(4–10)-treatment was started either 1 week before or 1 week after AF64A-injection. The efficacy of ACTH(4–10) was determined by measuring changes in cholinergic and serotonergic markers in the hippocampus.

Keywords

Septal Lesion Cholinergic Deficit Serotonergic Fiber Choline Acetyl Neurotrophic Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bijlsma, W.A., Jennekens, F.G.I., Shotman, P., and Gispen, W.-H., 1983, Stimulation by ACTH4–10 of nerve fiber regeneration following nerve crush, Muscle and Nerve 6: 104.PubMedCrossRefGoogle Scholar
  2. Daval, J.-L., Louis, J.-C., Gerard, M.-J., and Vincendon, G., 1983, Influence of adrenocorticotropic hormone on the growth of isolated neurons in cell culture, Neurosci.Lett. 36: 299.PubMedCrossRefGoogle Scholar
  3. DeWied, D., 1969, Effects of peptide hormones on behavior, in: “Frontiers in Neuroendocrinology”, W.F.Ganong, L.Martini, eds., Oxford University Press, New York.Google Scholar
  4. Edwards, P.M., Van der Zee, C.E.E.M., Verhaagen, J., Schotman, P., Jennekens, F.G.I., and Gispen, W.-H., 1984, Evidence that the neurotrophic action of MSH may derive its ability to mimic actions of a peptide formed in degenerating nerve stumps, J. Neurol. Sci. 64: 333.PubMedCrossRefGoogle Scholar
  5. Fonnum, F., 1969, Radiochemical microassay for determination of choline acetyltransferase and acetylcholinesterase activities, Biochem. J. 115: 465.PubMedGoogle Scholar
  6. Gaillard, A.W.K., and Vaery, C.A., 1979, Some effects of an ACTH4–9 analog (Org 2766) on human performance, Physiol.Behay. 23: 79.CrossRefGoogle Scholar
  7. Gerritsen van der Hoop, R., Vecht, C.J., Van der Burg, M.E.L., Elderson, A., Boogerd, W., Heimans, J.J., Els, D., Vries, P., Van Houwelingen, J.C., Jennekens, F.G.I., Gispen, W.-H., and Neijt, J.P., 1990, Prevention of cisplatin neurotoxicity with an ACTH(4–9) analogue in patients with ovarian cancer, N.Engl.J.Med. 322: 89.Google Scholar
  8. Gispen, W.-H., 1990, Therapeutic potential for melanocortins in peripheral nerve disece, Trends Pharmac. Sci. 11: 221.CrossRefGoogle Scholar
  9. Hamers, F.P.T., Pette, C., Neijt, J.P., and Gispen, W.-H., 1993, The ACTH-(4–9) analog, ORG 2766, prevents taxol-induced neuropathy in rats, Eur.J.Pharmacol. 233: 177.PubMedCrossRefGoogle Scholar
  10. Hock, F.J., Gerhards, H.J., Wiemer, G., Usinger, P., and Geiger, R., 1988, Learning and memory processes of an ACTH4–9 analog (Ebiratide; Hoe 427) in mice and rats, Peptides 9: 575.PubMedCrossRefGoogle Scholar
  11. Hörtnagl, H., Potter, P.E., and Hanin, I., 1987, Effect of cholinergic deficit induced by ethylcholine aziridinium on serotonergic parameters in rat brain. Neuroscience 22: 203.PubMedCrossRefGoogle Scholar
  12. Isaacson, R.L., and Poplawsky, A., 1983, An ACTH(4–9) analog (ORG 2766) speeds recovery from septal hyperemotionality in the rat, Behay.Neural.Biol. 39: 52.CrossRefGoogle Scholar
  13. Jolkkonen, J.T., Soininen, H.S., and Riekkinen, P.J., 1985, The effect of ACTH4–9 analog (ORG 2766) on some cerebrospinal fluid parameters in patients with Alzheimer’s dis’acP, Life. Sci. 37: 585.PubMedCrossRefGoogle Scholar
  14. König, J.F.R., and Kuppel, R.A., 1970, “The Rat Brain, A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brainstem”, Krieger, Huntington, New York.Google Scholar
  15. Landfield, P.W., Baskin, R.K., and Pitler, T.A., 1981, Brain aging correlates: retardation by hormonal-pharmacological treatments, Science 214: 581.PubMedCrossRefGoogle Scholar
  16. McDaniel, W.F., Jones, P.D., and Weaver, T.L., 1991, Medial frontal lesions, postoperative treatment with an ACTH(4–9) analog, and acquisition of a win-shift spatial strategy, Behay.Brain Res. 44: 107.CrossRefGoogle Scholar
  17. Miller, T.P., Fong, K., and Tinklenberg, J.R., 1993, An ACTH 4–9 analog (Org 2766) and cognitive performance: high-dose efficacy and safety in dementia of the Alzheimer’s type, Biol. Psychiatry 33: 307.PubMedCrossRefGoogle Scholar
  18. Nyakas, C., Veldhuis, H.D., and DeWied, D., 1985, Beneficial effect of chronic treatment with Org 2766 and-MSH on impaired reversal learning of rats with bilateral lesions of the parafascicular area, Brain Res. Bull. 15: 257.PubMedCrossRefGoogle Scholar
  19. Speck, G., 1982, Simultaneous determination of serotonin, 5-hydroxyindoleacetic acid, 3,4dihydroxyphenylacetic acid and homovanillic acid by high performance liquid chromatography with electrochemical detection, J.Neurochem. 38: 840.CrossRefGoogle Scholar
  20. Strand, F.L., and Kung, T.T., 1980, ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve, Peptides 1: 135.PubMedCrossRefGoogle Scholar
  21. Tonnaer, J.A.D.M., Schuijers, G.J.P.T., Van Diepen, H.A., and Peeters, B.W.M.M., 1992, Enhancement of regeneration by Org 2766 after nerve crush depends on the type of neural injury, Eur.J.Pharmacol. 214: 33.PubMedCrossRefGoogle Scholar
  22. Van der Neut, R., Biir, P.R., Sodaar, P., and Gispen, W.-H., 1988, Trophic influences of-MSH and ACTH(4–10) on neuronal outgrowth in vitro, Peptides 9: 1015.PubMedCrossRefGoogle Scholar
  23. Van der Zee, C.E.E.M., Van den Buuse, M., and Gispen, W.-H., 1990, Beneficial effect of an ACTH(4–9) analog on peripheral neuropathy and blood pressure response to tyramine in streptozocin diabetic rats, Eur.J.Pharmacol. 177: 211.PubMedCrossRefGoogle Scholar
  24. Van Luijtelaar, M.G.P.A., Tonnaer, J.A.D.M., and Steinbusch, H.W.W., 1992, Serotonergic fibres degenerating in the aging rat brain or sprouting from grafted fetal neurons are not affected by the neurotrophic ACTH analogue Org 2766, J. Chem. Neuroanatomy 5: 315.CrossRefGoogle Scholar
  25. Wiemer, G., Gerhards, H.J., Hock, F.J., Usinger, P., Von Rechenberg, W., and Geiger, R., 1988, Neurochemical effects of the synthetic ACTH49 analog Hoe 427 (Ebiratide) in rat brain, Peptides 9: 1081.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Heide Hörtnagl
    • 1
  • Grazyna Sobal
    • 1
  • Oleh Hornykiewicz
    • 1
  1. 1.Institute of Biochemical PharmacologyUniversity of ViennaViennaAustria

Personalised recommendations